Caffeoylquinic Acids from Aster tataricus Leaves Inhibit Aldose Reductase and Attenuate Hyaloid-Retinal Vasodilation in a Zebrafish Model of Hyperglycemia

Abstract

Diabetic retinopathy (DR) is a leading cause of blindness, and its pathogenesis is strongly linked to the activation of aldose reductase (AR) under hyperglycemic conditions. Developing effective AR inhibitors (ARIs), particularly from natural sources, remains a critical therapeutic goal. This study investigated the AR inhibitory potential of an 80% ethanol extract from the leaves of Aster tataricus. Using UPLC-Q-Orbitrap-MS, we identified 11 major compounds, with caffeoylquinic acids (CQAs) being predominant. In vitro assays on rat lens aldose reductase (RLAR) revealed that di-caffeoylquinic acids (di-CQAs), particularly 3,5-di-O-caffeoylquinic acid (3,5-DCQA; IC₅₀ = 0.31 µM), were potent noncompetitive inhibitors. Molecular docking simulations provided insights into their binding modes within the enzyme. The therapeutic relevance of these findings was confirmed in vivo using a larval zebrafish model of hyperglycemia, where both the A. tataricus extract and its constituent CQAs significantly suppressed hyaloid-retinal vessel dilation without inducing toxicity. Quantitative HPLC analysis confirmed that 3,5-DCQA was the most abundant di-CQA in the extract. These findings establish the CQA constituents of A. tataricus leaves as promising natural product leads for developing therapeutics to manage early-stage diabetic retinopathy.

Keywords

Aster tataricus - Asteraceae - caffeoylquinic acids - diabetic retinopathy - rat lens aldose reductase - zebrafish - molecular docking

Publication History

Received: 21 August 2025

Accepted after revision: 11 November 2025

Accepted Manuscript online:
11 November 2025

Article published online:
26 November 2025

• References

• 1 Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng CY. Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology 2021; 128: 1580-1591
• 2 Dănilă AI, Ghenciu LA, Stoicescu ER, Bolintineanu SL, Iacob R, Săndesc MA, Faur AC. Aldose reductase as a key target in the prevention and treatment of diabetic retinopathy: A comprehensive review. Biomedicines 2024; 12: 747
• 3 Toh H, Smolentsev A, Bozadjian RV, Keeley PW, Lockwood MD, Sadjadi R, Clegg DO, Blodi BA, Coffey PJ, Reese BE, Thomson JA. Vascular changes in diabetic retinopathy-a longitudinal study in the Nile rat. Lab Invest 2019; 99: 1547-1560
• 4 Wei L, Sun X, Fan C, Li R, Zhou S, Yu H. The pathophysiological mechanisms underlying diabetic retinopathy. Front Cell Dev Biol 2022; 10: 963615
• 5 Stewart MW. Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J Diabetes 2016; 7: 333-341
• 6 Simó R, Hernández C. New insights into treating early and advanced stage diabetic retinopathy. Int J Mol Sci 2022; 23: 8513
• 7 Wallsh JO, Gallemore RP. Anti-VEGF-resistant retinal diseases: A review of the latest treatment options. Cells 2021; 10: 1049
• 8 Chang KC, Shieh B, Petrash JM. Role of aldose reductase in diabetes-induced retinal microglia activation. Chem Biol Interact 2019; 302: 46-52
• 9 Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: Attractive, elusive, and resilient. J Diabetes Res 2007; 2007: 061038
• 10 DʼAndrea F, Sartini S, Piano I, Franceschi M, Quattrini L, Guazzelli L, Ciccone L, Orlandini E, Gargini C, La Motta C, Nencetti S. Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity. J Enzyme Inhib Med Chem 2020; 35: 1194-1205
• 11 Zhang X, Liu M, Zhang X, Ma L, Song S, Pan M, Huang S, Ren W, Ma W. L. f.: A review on the botany, phytochemistry, ethnopharmacology, pharmacology, toxicology and comprehensive utilization. Front Pharmacol 2025; 16: 1581505
• 12 Li KJ, Liu YY, Wang D, Yan PZ, Lu DC, Zhao DS. Radix asteris: Traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine. Molecules 2022; 27: 5388
• 13 Yu P, Cheng S, Xiang J, Yu B, Zhang M, Zhang C, Xu X. Expectorant, antitussive, anti-inflammatory activities and compositional analysis of. J Ethnopharmacol 2015; 164: 328-333
• 14 Yang J, Yao L, Gong K, Li K, Sun L, Cai W. Identification and quantification of chlorogenic acids from the root bark of by UHPLC-Q-exactive orbitrap mass spectrometry. ACS Omega 2022; 7: 25675-25685
• 15 Zhang Y, Xiong H, Xu X, Xue X, Liu M, Xu S, Liu H, Gao Y, Zhang H, Li X. Compounds identification in semen cuscutae by Ultra-High-Performance Liquid Chromatography (UPLCs) coupled to electrospray ionization mass spectrometry. Molecules 2018; 23: 1199
• 16 Clifford MN, Johnston KL, Knight S, Kuhnert N. Hierarchical scheme for LC-MSn identification of chlorogenic acids. J Agric Food Chem 2003; 51: 2900-2911
• 17 Zuo G, Kim HY, Guillen Quispe YN, Wang Z, Kim KH, Gonzales Arce PH, Lim SS. Ruiz & Pav. root extract: A new source of caffeoylquinic acids with antioxidant and aldose reductase inhibitory activities. Foods 2021; 10: 1079
• 18 Kalita D, Holm DG, LaBarbera DV, Petrash JM, Jayanty SS. Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds. PLoS One 2018; 13: e0191025
• 19 Ali MY, Zaib S, Jannat S, Khan I, Rahman MM, Park SK, Chang MS. Inhibition of aldose reductase by ginsenoside derivatives via a specific structure activity relationship with kinetics mechanism and molecular docking study. Molecules 2022; 27: 2134
• 20 Balestri F, Cappiello M, Moschini R, Mura U, Del-Corso A. Models of enzyme inhibition and apparent dissociation constants from kinetic analysis to study the differential inhibition of aldose reductase. J Enzyme Inhib Med Chem 2022; 37: 1426-1436
• 21 Prieto-Martínez F, Arciniega M, Medina-Franco J. Molecular docking: Current advances and challenges. TIP Rev Espec Cienc Quím-Biol 2018; 21: 65-87
• 22 Chang CA, Chen W, Gilson MK. Ligand configurational entropy and protein binding. Proc Natl Acad Sci 2007; 104: 1534-1539
• 23 Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS. Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. J Med Chem 2004; 47: 1739-1749
• 24 Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov 2004; 3: 935-949
• 25 Jung SH, Kim YS, Lee YR, Kim JS. High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: A short-term animal model of diabetic retinopathy. Br J Pharmacol 2016; 173: 15-26
• 26 Middel CS, Hammes HP, Kroll J. Advancing diabetic retinopathy research: Analysis of the neurovascular unit in zebrafish. Cells 2021; 10: 1313
• 27 Chhetri J, Jacobson G, Gueven N. Zebrafish–On the move towards ophthalmological research. Eye (Lond) 2014; 28: 367-380
• 28 Xie J, Farage E, Sugimoto M, Anand-Apte B. A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development. BMC Dev Biol 2010; 10: 76
• 29 Veeresham C, Rama Rao A, Asres K. Aldose reductase inhibitors of plant origin. Phytother Res 2014; 28: 317-333
• 30 Oka M, Kato N. Aldose reductase inhibitors. J Enzyme Inhib 2001; 16: 465-473
• 31 Sarges R, Peterson MJ. Sorbinil: A member of the novel class of spirohydantoin aldose reductase inhibitors. Metabolism 1986; 35: 101-104
• 32 Hufnagel M, Rademaekers A, Weisert A, Häberlein H, Franken S. Pharmacological profile of dicaffeoylquinic acids and their role in the treatment of respiratory diseases. Front Pharmacol 2024; 15: 1371613
• 33 Wittemer SM, Ploch M, Windeck T, Müller SC, Drewelow B, Derendorf H, Veit M. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine 2005; 12: 28-38
• 34 Putu N, Hikmawanti NPE, Saputri F, Yanuar A, Jantan I, Yeni Y, Munʼim A. A computational approach to evaluate caffeoylquinic acids and flavonoids in Pluchea indica Less. leaves as potential anti-HIV agents. J Pharm Pharmacogn Res 2024; 12: 701-721
• 35 Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 455-461
• 36 Furey A. Method validation: A complex concept. Pharm Methods 2011; 2: 1-12